ID   ACOX1_HUMAN             Reviewed;         660 AA.
AC   Q15067; A8K6X8; A8KAA0; B4DK61; F5GYQ8; Q12863; Q15068; Q15101;
AC   Q16131; Q7Z3W5; Q9UD31;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 3.
DT   15-MAR-2017, entry version 176.
DE   RecName: Full=Peroxisomal acyl-coenzyme A oxidase 1;
DE            Short=AOX;
DE            EC=1.3.3.6;
DE   AltName: Full=Palmitoyl-CoA oxidase;
DE   AltName: Full=Straight-chain acyl-CoA oxidase;
DE            Short=SCOX;
GN   Name=ACOX1; Synonyms=ACOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=8159712; DOI=10.1073/pnas.91.8.3107;
RA   Varanasi U., Chu R., Chu S., Espinosa R., Lebeau M.M., Reddy J.K.;
RT   "Isolation of the human peroxisomal acyl-CoA oxidase gene:
RT   organization, promoter analysis, and chromosomal localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3107-3111(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7876265; DOI=10.1074/jbc.270.9.4908;
RA   Chu R., Varanasi U., Chu S., Lin Y., Usuda N., Rao M.S., Reddy J.K.;
RT   "Overexpression and characterization of the human peroxisomal acyl-CoA
RT   oxidase in insect cells.";
RL   J. Biol. Chem. 270:4908-4915(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT MET-312, AND
RP   INVOLVEMENT IN PSEUDO-NALD.
RC   TISSUE=Liver;
RX   PubMed=8040306; DOI=10.1172/JCI117365;
RA   Fourner B., Saudubray J.-M., Benichou B., Lyonnet S., Munnich A.,
RA   Clevers H., Poll-The B.T.;
RT   "Large deletion of the peroxisomal acyl-CoA oxidase gene in
RT   pseudoneonatal adrenoleukodystrophy.";
RL   J. Clin. Invest. 94:526-531(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-312.
RC   TISSUE=Liver;
RX   PubMed=8117268; DOI=10.1006/bbrc.1994.1158;
RA   Aoyama T., Tsushima K., Souri M., Kamijo T., Suzuki Y., Shimozawa N.,
RA   Orii T., Hashimoto T.;
RT   "Molecular cloning and functional expression of a human peroxisomal
RT   acyl-coenzyme A oxidase.";
RL   Biochem. Biophys. Res. Commun. 198:1113-1118(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3), AND
RP   VARIANT MET-312.
RC   TISSUE=Placenta, Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   MET-312.
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-153 AND MET-312.
RC   TISSUE=Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=17603022; DOI=10.1016/j.bbrc.2007.06.059;
RA   Oaxaca-Castillo D., Andreoletti P., Vluggens A., Yu S.,
RA   van Veldhoven P.P., Reddy J.K., Cherkaoui-Malki M.;
RT   "Biochemical characterization of two functional human liver acyl-CoA
RT   oxidase isoforms 1a and 1b encoded by a single gene.";
RL   Biochem. Biophys. Res. Commun. 360:314-319(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-255; LYS-267; LYS-437;
RP   LYS-500 AND LYS-504, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   TISSUE SPECIFICITY, AND REVERSAL OF ACOX1 NULL PHENOTYPE IN MOUSE.
RX   PubMed=20195242; DOI=10.1038/labinvest.2010.46;
RA   Vluggens A., Andreoletti P., Viswakarma N., Jia Y., Matsumoto K.,
RA   Kulik W., Khan M., Huang J., Guo D., Yu S., Sarkar J., Singh I.,
RA   Rao M.S., Wanders R.J., Reddy J.K., Cherkaoui-Malki M.;
RT   "Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human
RT   ACOX1b isoform.";
RL   Lab. Invest. 90:696-708(2010).
RN   [15]
RP   ERRATUM.
RA   Vluggens A., Andreoletti P., Viswakarma N., Jia Y., Matsumoto K.,
RA   Kulik W., Khan M., Huang J., Guo D., Yu S., Sarkar J., Singh I.,
RA   Rao M.S., Wanders R.J., Reddy J.K., Cherkaoui-Malki M.;
RL   Lab. Invest. 90:808-808(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   VARIANTS PSEUDO-NALD CYS-178 AND VAL-278.
RX   PubMed=11815777; DOI=10.1067/mpd.2002.120511;
RA   Suzuki Y., Iai M., Kamei A., Tanabe Y., Chida S., Yamaguchi S.,
RA   Zhang Z., Takemoto Y., Shimozawa N., Kondo N.;
RT   "Peroxisomal acyl-CoA oxidase deficiency.";
RL   J. Pediatr. 140:128-130(2002).
RN   [21]
RP   VARIANTS PSEUDO-NALD VAL-64 DEL; CYS-178; LEU-184; VAL-231; VAL-278;
RP   ARG-309 AND PRO-310, AND FUNCTION.
RX   PubMed=17458872; DOI=10.1002/humu.20535;
RA   Ferdinandusse S., Denis S., Hogenhout E.M., Koster J.,
RA   van Roermund C.W., Ijlst L., Moser A.B., Wanders R.J., Waterham H.R.;
RT   "Clinical, biochemical, and mutational spectrum of peroxisomal acyl-
RT   coenzyme A oxidase deficiency.";
RL   Hum. Mutat. 28:904-912(2007).
CC   -!- FUNCTION: Catalyzes the desaturation of acyl-CoAs to 2-trans-
CC       enoyl-CoAs. Isoform 1 shows highest activity against medium-chain
CC       fatty acyl-CoAs and activity decreases with increasing chain
CC       length. Isoform 2 is active against a much broader range of
CC       substrates and shows activity towards very long-chain acyl-CoAs.
CC       Isoform 2 is twice as active as isoform 1 against 16-hydroxy-
CC       palmitoyl-CoA and is 25% more active against 1,16-hexadecanodioyl-
CC       CoA. {ECO:0000269|PubMed:17458872, ECO:0000269|PubMed:17603022}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + O(2) = trans-2,3-dehydroacyl-CoA +
CC       H(2)O(2).
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17603022};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=73 uM for palmitoyl-CoA (isoform 1)
CC         {ECO:0000269|PubMed:17603022};
CC         KM=90 uM for palmitoyl-CoA (isoform 2)
CC         {ECO:0000269|PubMed:17603022};
CC       pH dependence:
CC         Optimum pH is 8.5 for isoform 1 and 7.5-8.5 for isoform 2.
CC         {ECO:0000269|PubMed:17603022};
CC       Temperature dependence:
CC         Optimum temperature for isoform 1 at pH 7.5 is 40 degrees
CC         Celsius with no activity at 50 degrees Celsius. Optimum
CC         temperature for isoform 2 at pH 7.5 is 47.5 degrees Celsius with
CC         57% activity retained at 50 degrees Celsius.
CC         {ECO:0000269|PubMed:17603022};
CC   -!- PATHWAY: Lipid metabolism; peroxisomal fatty acid beta-oxidation.
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=ACOX1a, SCOX-exon 3I;
CC         IsoId=Q15067-1; Sequence=Displayed;
CC       Name=2; Synonyms=ACOX1b, SCOX-exon 3II;
CC         IsoId=Q15067-2; Sequence=VSP_000146;
CC       Name=3;
CC         IsoId=Q15067-3; Sequence=VSP_046129, VSP_000146;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels of
CC       isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed
CC       at higher levels than isoform 2 in liver and kidney while isoform
CC       2 levels are higher in brain, lung, muscle, white adipose tissue
CC       and testis. Levels are almost equal in heart.
CC       {ECO:0000269|PubMed:17603022, ECO:0000269|PubMed:20195242}.
CC   -!- DISEASE: Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD)
CC       [MIM:264470]: A peroxisomal single-enzyme disorder of fatty acid
CC       beta-oxidation, resulting in clinical manifestations that remind
CC       neonatal adrenoleukodystrophy. Clinical features include mental
CC       retardation, leukodystrophy, seizures, mild hepatomegaly, hearing
CC       deficit. Pseudo-NALD is characterized by increased plasma levels
CC       of very-long chain fatty acids, due to decreased or absent
CC       peroxisome acyl-CoA oxidase activity. Peroxisomes are intact and
CC       functioning. {ECO:0000269|PubMed:11815777,
CC       ECO:0000269|PubMed:17458872, ECO:0000269|PubMed:8040306}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- MISCELLANEOUS: Isoform 1 and isoform 2 can reverse the Acox1 null
CC       phenotype in mouse which is characterized by severe microvesicular
CC       hepatic steatosis, sustained activation of Ppara, spontaneous
CC       massive peroxisome proliferation and eventual development of
CC       hepatocellular carcinomas. Isoform 2 is more effective in reversal
CC       of the phenotype than isoform 1 (PubMed:20195242).
CC       {ECO:0000305|PubMed:20195242}.
CC   -!- SIMILARITY: Belongs to the acyl-CoA oxidase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD97622.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03268; AAA19113.1; -; Genomic_DNA.
DR   EMBL; U03254; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03255; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03256; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03258; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03259; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03260; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03261; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03263; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03264; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03265; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03266; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03267; AAA19113.1; JOINED; Genomic_DNA.
DR   EMBL; U03268; AAA19114.1; -; Genomic_DNA.
DR   EMBL; U03254; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03255; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03257; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03258; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03259; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03260; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03261; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03263; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03264; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03265; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03266; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U03267; AAA19114.1; JOINED; Genomic_DNA.
DR   EMBL; U07866; AAA18595.1; -; mRNA.
DR   EMBL; X71440; CAA50574.1; -; mRNA.
DR   EMBL; S69189; AAB30019.2; -; mRNA.
DR   EMBL; AK291793; BAF84482.1; -; mRNA.
DR   EMBL; AK292965; BAF85654.1; -; mRNA.
DR   EMBL; AK296409; BAG59073.1; -; mRNA.
DR   EMBL; BX537380; CAD97622.1; ALT_INIT; mRNA.
DR   EMBL; AC040980; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087289; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89351.1; -; Genomic_DNA.
DR   EMBL; BC008767; AAH08767.1; -; mRNA.
DR   EMBL; BC010425; AAH10425.1; -; mRNA.
DR   CCDS; CCDS11734.1; -. [Q15067-2]
DR   CCDS; CCDS11735.1; -. [Q15067-1]
DR   PIR; A54942; A54942.
DR   PIR; B54942; B54942.
DR   PIR; I38095; I38095.
DR   RefSeq; NP_001171968.1; NM_001185039.1. [Q15067-3]
DR   RefSeq; NP_004026.2; NM_004035.6. [Q15067-2]
DR   RefSeq; NP_009223.2; NM_007292.5. [Q15067-1]
DR   UniGene; Hs.464137; -.
DR   ProteinModelPortal; Q15067; -.
DR   SMR; Q15067; -.
DR   BioGrid; 106567; 36.
DR   IntAct; Q15067; 8.
DR   MINT; MINT-4717708; -.
DR   STRING; 9606.ENSP00000293217; -.
DR   DrugBank; DB07930; (3R)-3-HYDROXYDODECANOIC ACID.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   SwissLipids; SLP:000000536; -. [Q15067-1]
DR   SwissLipids; SLP:000000537; -. [Q15067-2]
DR   iPTMnet; Q15067; -.
DR   PhosphoSitePlus; Q15067; -.
DR   SwissPalm; Q15067; -.
DR   BioMuta; ACOX1; -.
DR   DMDM; 126302511; -.
DR   EPD; Q15067; -.
DR   MaxQB; Q15067; -.
DR   PaxDb; Q15067; -.
DR   PeptideAtlas; Q15067; -.
DR   PRIDE; Q15067; -.
DR   TopDownProteomics; Q15067-1; -. [Q15067-1]
DR   DNASU; 51; -.
DR   Ensembl; ENST00000293217; ENSP00000293217; ENSG00000161533. [Q15067-2]
DR   Ensembl; ENST00000301608; ENSP00000301608; ENSG00000161533. [Q15067-1]
DR   GeneID; 51; -.
DR   KEGG; hsa:51; -.
DR   UCSC; uc002jqe.5; human. [Q15067-1]
DR   CTD; 51; -.
DR   DisGeNET; 51; -.
DR   GeneCards; ACOX1; -.
DR   HGNC; HGNC:119; ACOX1.
DR   HPA; CAB021094; -.
DR   HPA; HPA021192; -.
DR   HPA; HPA021195; -.
DR   HPA; HPA028759; -.
DR   MalaCards; ACOX1; -.
DR   MIM; 264470; phenotype.
DR   MIM; 609751; gene.
DR   neXtProt; NX_Q15067; -.
DR   OpenTargets; ENSG00000161533; -.
DR   Orphanet; 2971; Peroxisomal acyl-CoA oxidase deficiency.
DR   PharmGKB; PA21; -.
DR   eggNOG; KOG0136; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00530000062919; -.
DR   HOVERGEN; HBG050451; -.
DR   InParanoid; Q15067; -.
DR   KO; K00232; -.
DR   OMA; IRELGTH; -.
DR   OrthoDB; EOG091G0A1P; -.
DR   PhylomeDB; Q15067; -.
DR   TreeFam; TF300672; -.
DR   BioCyc; MetaCyc:HS08589-MONOMER; -.
DR   BRENDA; 1.3.3.6; 2681.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-390247; Beta-oxidation of very long chain fatty acids.
DR   SABIO-RK; Q15067; -.
DR   UniPathway; UPA00661; -.
DR   ChiTaRS; ACOX1; human.
DR   GeneWiki; ACOX1; -.
DR   GenomeRNAi; 51; -.
DR   PRO; PR:Q15067; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000161533; -.
DR   CleanEx; HS_ACOX1; -.
DR   ExpressionAtlas; Q15067; baseline and differential.
DR   Genevisible; Q15067; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:Ensembl.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; IEA:InterPro.
DR   GO; GO:0003997; F:acyl-CoA oxidase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0016401; F:palmitoyl-CoA oxidase activity; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:MGI.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; IMP:BHF-UCL.
DR   GO; GO:0019395; P:fatty acid oxidation; IMP:UniProtKB.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; IMP:UniProtKB.
DR   GO; GO:0055088; P:lipid homeostasis; IDA:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IDA:UniProtKB.
DR   GO; GO:0016559; P:peroxisome fission; IGI:UniProtKB.
DR   GO; GO:2000189; P:positive regulation of cholesterol homeostasis; IGI:UniProtKB.
DR   GO; GO:0006693; P:prostaglandin metabolic process; IMP:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0000038; P:very long-chain fatty acid metabolic process; IMP:BHF-UCL.
DR   CDD; cd01150; AXO; 1.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR034171; ACO.
DR   InterPro; IPR029320; Acyl-CoA_ox_N.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR012258; Acyl-CoA_oxidase.
DR   InterPro; IPR002655; Acyl-CoA_oxidase_C.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF01756; ACOX; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF14749; Acyl-CoA_ox_N; 1.
DR   PIRSF; PIRSF000168; Acyl-CoA_oxidase; 1.
DR   SUPFAM; SSF47203; SSF47203; 2.
DR   SUPFAM; SSF56645; SSF56645; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; FAD; Fatty acid metabolism; Flavoprotein;
KW   Lipid metabolism; Oxidoreductase; Peroxisome; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    660       Peroxisomal acyl-coenzyme A oxidase 1.
FT                                /FTId=PRO_0000204677.
FT   MOTIF       658    660       Microbody targeting signal.
FT   ACT_SITE    421    421       Proton acceptor. {ECO:0000250}.
FT   BINDING     139    139       FAD. {ECO:0000250}.
FT   BINDING     178    178       FAD; via amide nitrogen. {ECO:0000250}.
FT   MOD_RES      26     26       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      89     89       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES      90     90       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     216    216       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     241    241       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     255    255       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     267    267       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     272    272       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     349    349       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     437    437       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     437    437       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     446    446       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     446    446       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     500    500       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     504    504       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     512    512       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     512    512       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     542    542       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     637    637       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     637    637       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     643    643       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     649    649       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     651    651       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   MOD_RES     654    654       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R0H0}.
FT   VAR_SEQ       1     38       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046129.
FT   VAR_SEQ      90    131       KLHLVNFVEPVGLNYSMFIPTLLNQGTTAQKEKWLLSSKGL
FT                                Q -> NFVHRGRPEPLDLHLGMFLPTLLHQATAEQQERFFM
FT                                PAWNLE (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:8040306}.
FT                                /FTId=VSP_000146.
FT   VARIANT      64     64       Missing (in pseudo-NALD).
FT                                {ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_067040.
FT   VARIANT     101    101       G -> S (in dbSNP:rs3744032).
FT                                /FTId=VAR_048182.
FT   VARIANT     153    153       T -> I (in dbSNP:rs17855420).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030619.
FT   VARIANT     178    178       G -> C (in pseudo-NALD;
FT                                dbSNP:rs118204091).
FT                                {ECO:0000269|PubMed:11815777,
FT                                ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_025789.
FT   VARIANT     184    184       S -> L (in pseudo-NALD;
FT                                dbSNP:rs780887410).
FT                                {ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_067041.
FT   VARIANT     231    231       G -> V (in pseudo-NALD).
FT                                {ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_067042.
FT   VARIANT     278    278       M -> V (in pseudo-NALD;
FT                                dbSNP:rs118204090).
FT                                {ECO:0000269|PubMed:11815777,
FT                                ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_025790.
FT   VARIANT     309    309       Q -> R (in pseudo-NALD;
FT                                dbSNP:rs118204092).
FT                                {ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_067043.
FT   VARIANT     310    310       S -> P (in pseudo-NALD;
FT                                dbSNP:rs758962364).
FT                                {ECO:0000269|PubMed:17458872}.
FT                                /FTId=VAR_067044.
FT   VARIANT     312    312       I -> M (in dbSNP:rs1135640).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:8040306,
FT                                ECO:0000269|PubMed:8117268}.
FT                                /FTId=VAR_021529.
FT   CONFLICT     27     27       P -> L (in Ref. 3; CAA50574).
FT                                {ECO:0000305}.
FT   CONFLICT     80     80       A -> R (in Ref. 3; CAA50574).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       E -> D (in Ref. 6; CAD97622).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       Q -> E (in Ref. 4; AAB30019).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       Y -> H (in Ref. 2; AAA18595).
FT                                {ECO:0000305}.
FT   CONFLICT    212    213       IG -> NR (in Ref. 1; AAA19113/AAA19114
FT                                and 2; AAA18595). {ECO:0000305}.
FT   CONFLICT    264    264       T -> P (in Ref. 1; AAA19113/AAA19114 and
FT                                2; AAA18595). {ECO:0000305}.
FT   CONFLICT    332    332       F -> L (in Ref. 2; AAA18595).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       C -> R (in Ref. 2; AAA18595).
FT                                {ECO:0000305}.
FT   CONFLICT    490    490       R -> L (in Ref. 5; BAF85654).
FT                                {ECO:0000305}.
FT   CONFLICT    531    531       C -> L (in Ref. 1; AAA19113/AAA19114 and
FT                                2; AAA18595). {ECO:0000305}.
FT   CONFLICT    534    535       VV -> GL (in Ref. 1; AAA19113/AAA19114
FT                                and 2; AAA18595). {ECO:0000305}.
FT   CONFLICT    615    615       V -> A (in Ref. 3; CAA50574).
FT                                {ECO:0000305}.
FT   CONFLICT    650    650       Y -> YH (in Ref. 4; AAB30019).
FT                                {ECO:0000305}.
SQ   SEQUENCE   660 AA;  74424 MW;  D713768A47374EA1 CRC64;
     MNPDLRRERD SASFNPELLT HILDGSPEKT RRRREIENMI LNDPDFQHED LNFLTRSQRY
     EVAVRKSAIM VKKMREFGIA DPDEIMWFKK LHLVNFVEPV GLNYSMFIPT LLNQGTTAQK
     EKWLLSSKGL QIIGTYAQTE MGHGTHLRGL ETTATYDPET QEFILNSPTV TSIKWWPGGL
     GKTSNHAIVL AQLITKGKCY GLHAFIVPIR EIGTHKPLPG ITVGDIGPKF GYDEIDNGYL
     KMDNHRIPRE NMLMKYAQVK PDGTYVKPLS NKLTYGTMVF VRSFLVGEAA RALSKACTIA
     IRYSAVRHQS EIKPGEPEPQ ILDFQTQQYK LFPLLATAYA FQFVGAYMKE TYHRINEGIG
     QGDLSELPEL HALTAGLKAF TSWTANTGIE ACRMACGGHG YSHCSGLPNI YVNFTPSCTF
     EGENTVMMLQ TARFLMKSYD QVHSGKLVCG MVSYLNDLPS QRIQPQQVAV WPTMVDINSP
     ESLTEAYKLR AARLVEIAAK NLQKEVIHRK SKEVAWNLTS VDLVRASEAH CHYVVVKLFS
     EKLLKIQDKA IQAVLRSLCL LYSLYGISQN AGDFLQGSIM TEPQITQVNQ RVKELLTLIR
     SDAVALVDAF DFQDVTLGSV LGRYDGNVYE NLFEWAKNSP LNKAEVHESY KHLKSLQSKL
//
